Allergy treatment using oral drops (also known as sublingual immunotherapy) is endorsed by the World Health Organization and ARIA (Allergic Rhinitis and its Impact on Asthma) guidelines. Dozens of studies conducted worldwide have confirmed its safety and efficacy. In addition, our studies show that more than 80 percent of allergic patients and more than 90 percent of asthmatics report symptom relief within the first few months of receiving oral drops therapy at the Family Allergy Clinic.

“SLIT [sublingual immunotherapy] is a safe treatment which significantly reduces symptoms and medication requirements in allergic rhinitis.”
–The Cochrane Review

“Thus far studies have found that drops were as effective as shots and, not surprisingly, were better accepted by patients and were safer.”
–Scientific American, “Drink Your Shots,” April 2002

The Journal of Allergy and Clinical Immunology identified sublingual immunotherapy as efficacious, particularly for certain populations (young children, severely reactive).